Skip to content

Organ Transplant Rejection

Organ transplant rejection happens when the immune system identifies a donated organ or tissue as foreign and attacks it. It can affect how the transplant works, so ongoing treatment aims to reduce this immune response.

Imuran

Azathioprine

25mg · 50mg

Utilised to manage chronic immune hyperactivity to alleviate joint tissue damage and support organ transplant viability.

From$1.55/ tabletView

Neoral

Ciclosporin

25mg · 100mg

Utilised to manage severe autoimmune skin lesions to alleviate scaling and support normal epidermal development.

From$4.16/ capsuleView

Prograf

Tacrolimus

0.5mg · 1mg · 5mg

Intended to relieve transplant rejection risks to support physical organ viability and target immune responses.

From$3.34/ tabletView

Cellcept

Mycophenolate Mofetil

250mg · 500mg

Formulated to alleviate immunological transplant rejection risks to support organ function and target T-lymphocyte proliferation.

From$2.91/ capsuleView

Ciclosporin Capsules

Ciclosporin

50mg · 100mg

Intended to relieve autoimmune cell proliferation to support chronic organ viability and target inflammatory responses.

From$4.10/ capsuleView

Key points

  • Timing: Rejection may happen soon after a transplant or later on.
  • Effect: It can reduce how well the transplanted organ works.
  • Signs: Symptoms can differ depending on the organ or tissue that was transplanted.

Medicines listed for Organ Transplant Rejection

The five listed products contain four ingredients: Ciclosporin, azathioprine, Tacrolimus, and mycophenolate mofetil. Ciclosporin and tacrolimus are calcineurin inhibitors, while azathioprine and mycophenolate mofetil are other immunosuppressants. These medicine classes lower immune system activity, a role linked with organ transplant rejection.

Further reading